Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.95 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ASBP combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.95 |
| Market Cap | $8.09M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $11,832.00 |
| 52-Week Low | $3.31 |
| Volume | 1.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.20K |
| Net Income | $-24.48M |
| Gross Margin | 0.00% |
ASBP analyst coverage data. Average price target: $0.00.